Mojtaba Fathi

6PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 09, 2026
The Effect of Aminoguanidine on Fibrinogen Gene Expression and Oxidative Stress Biomarkers in the Liver Tissue of a Streptozotocin-Induced Diabetic Rat Model

Amir Karbalaee Hasani, Hosein Fallahi Kord Gheshlaghi, Mojtaba Fathi

|Dec 27, 2022
Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells.

Shabnam Shahidi, Kobra Rostamizadeh, Mojtaba Fathi

|Apr 13, 2022
Advanced Glycation End Product Blocker Drugs Have a Great Potential to Prevent Diabetic Cardiomyopathy in an Animal Model of Diabetes Mellitus Type-2.

Amir Hossein Heydari, Mojtaba Fathi, Sophia Heydari

|Feb 27, 2021
Clinicopathological, Immunohistochemical, and PMS2 Gene Expression Profiling of Patients with Sporadic Colorectal Cancer.

Maryam Mousavi, Mohammad Taghi Goodarzi, Seyed Mehrdad Kassaee

|Aug 24, 2018
Preliminary study showing no association between G238A (rs361525) tumor necrosis factor-α (TNF-α) gene polymorphism and its serum level, hormonal and biochemical aspects of polycystic ovary syndrome.

Fahimeh Kordestani, Sahar Mazloomi, Yousef Mortazavi

|Nov 24, 2017
Curcumin mediated down-regulation of αV β3 integrin and up-regulation of pyruvate dehydrogenase kinase 4 (PDK4) in Erlotinib resistant SW480 colon cancer cells.

Samira Javadi, Kobra Rostamizadeh, Jalal Hejazi

Pageof 1

Frequent Collaborators

1 joint publications

Maryam Mousavi

1 joint publications

Amir Hossein Heydari

1 joint publications

Sophia Heydari

1 joint publications

Mohammad Esmaeil Heidari